Voyager Therapeutics, Inc.

Associate Director, Regulatory Affairs CMC

Voyager Therapeutics, Inc. • $150K — $180K *
Pharmaceuticals & Biotech
8 - 10 years of experience

About Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company is focused on developing life-changing treatments for severe neurological diseases. Its pipeline includes programs for Parkinson's disease, Huntington's disease, Friedreich's ataxia, and other severe neurological diseases. The Company's clinical-stage programs include VY-AADC for Parkinson's disease, VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. The Company's preclinical programs include VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-TAU01 for Alzheimer's disease, and VY-NAV01 for severe chronic pain. The Company's gene therapy platform includes adeno-associated virus (AAV) vectors, which are naturally occurring, non-pathogenic viruses that are capable of delivering genetic material to cells. The Company has collaborations with Sanofi Genzyme, AbbVie, and Neurocrine Biosciences, Inc.
Learn more about Voyager Therapeutics, Inc.
Size
101 employees
Market Cap
$211.5 million
Industry
Net Income
$36.7 million
Founded
2013
5 Year Trend
+21.3%
Revenue
$171.1 million
NASDAQ

Similar Jobs

More Pharmaceuticals & Biotech Jobs

* Ladders Estimates